Published in Eur J Clin Nutr on August 01, 1999
Socioeconomic Inequality of Non-Communicable Risk Factors among People Living in Kurdistan Province, Islamic Republic of Iran. Int J Prev Med (2013) 0.88
Dietary behaviour and socioeconomic position: the role of physical activity patterns. PLoS One (2013) 0.82
Work and diet-related risk factors of cardiovascular diseases: comparison of two occupational groups. J Occup Med Toxicol (2010) 0.79
Effect of Socioeconomic Status on Propensity to Change Risk Behaviors Following Myocardial Infarction: Implications for Healthy Lifestyle Medicine. Prog Cardiovasc Dis (2017) 0.75
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med (1998) 25.66
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J (2003) 17.80
Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J (1991) 6.35
A comparison of diets with and without oats in adults with celiac disease. N Engl J Med (1995) 4.14
High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care (1998) 3.94
Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis (1998) 3.50
Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev (1987) 2.88
Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care (1998) 2.70
NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes (1994) 2.67
Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease. Diabetologia (2009) 2.63
Prevalence of age-associated memory impairment in a randomly selected population from eastern Finland. Neurology (1995) 2.44
Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia (1993) 2.41
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S) Circulation (1998) 2.40
Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S) Circulation (1997) 2.34
Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J (2002) 2.31
Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study. Arch Intern Med (2000) 2.27
Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study. Circulation (1996) 2.23
Diabetes, prediabetes and cancer mortality. Diabetologia (2010) 2.22
The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease. J Card Fail (1997) 2.08
Non-cardiovascular disease mortality and diabetes mellitus. Lancet (1997) 2.01
Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Circulation (1998) 1.98
Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke (1996) 1.97
Poor glycemic control predicts coronary heart disease events in patients with type 1 diabetes without nephropathy. Arterioscler Thromb Vasc Biol (1999) 1.95
Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation (1993) 1.90
Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland. Eur Heart J (1996) 1.82
Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. J Hypertens (1998) 1.80
Relationship of socioeconomic status to the incidence and prehospital, 28-day, and 1-year mortality rates of acute coronary events in the FINMONICA myocardial infarction register study. Circulation (2000) 1.79
Risk factors predicting lower extremity amputations in patients with NIDDM. Diabetes Care (1996) 1.78
Screening of family members of patients with premature coronary heart disease; results from the EUROASPIRE II family survey. Eur Heart J (2003) 1.77
The impact of an end-point committee in a large multicentre, randomized, placebo-controlled clinical trial: results with and without the end-point committee's final decision on end-points. Eur Heart J (1999) 1.72
Recessive inheritance of adult-type lactose malabsorption. Lancet (1973) 1.69
Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study. Arch Intern Med (1996) 1.68
Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies. Diabetologia (2004) 1.67
Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes (1997) 1.64
Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation (1999) 1.64
Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol (2000) 1.62
Hyperostosis of the spine in an adult population. Its relation to hyperglycaemia and obesity. Ann Rheum Dis (1971) 1.61
The Social Insurance Institution's coronary heart disease study. Baseline data and 5-year mortality experience. Acta Med Scand Suppl (1983) 1.59
Relation of socioeconomic position to the case fatality, prognosis and treatment of myocardial infarction events; the FINMONICA MI Register Study. J Epidemiol Community Health (2001) 1.57
Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki Policemen Study population. Acta Med Scand Suppl (1985) 1.52
Glucose tolerance and coronary heart disease: Helsinki policemen study. J Chronic Dis (1979) 1.52
Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up study. Diabetologia (2007) 1.50
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. Atheroscler Suppl (2004) 1.50
Association of angiotensin converting enzyme and plasminogen activator inhibitor-1 promoter gene polymorphisms with features of the insulin resistance syndrome in patients with premature coronary heart disease. Atherosclerosis (2001) 1.49
Oxidised LDL and progression of atherosclerosis. Lancet (1992) 1.49
Nutritional status of newly diagnosed celiac disease patients before and after the institution of a celiac disease diet--association with the grade of mucosal villous atrophy. Am J Clin Nutr (1998) 1.49
Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland. Clin Infect Dis (2001) 1.47
Impairment of diastolic function in middle-aged type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients free of cardiovascular disease. Diabetologia (1988) 1.46
Cholesterol lowering after participation in the Scandinavian Simvastatin Survival Study (4S) in Finland. Eur Heart J (1997) 1.46
Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study. Diabetologia (2004) 1.46
Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study. Diabetes Care (1999) 1.43
Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering. Am J Cardiol (2000) 1.43
Differences in the treatment of coronary heart disease between countries as revealed in the Scandinavian Simvastatin Survival Study (4S) Eur Heart J (1998) 1.42
Gender differences in recurrent coronary events; the FINMONICA MI register. Eur Heart J (2001) 1.41
Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment. Eur Heart J (2001) 1.41
Low-grade systolic murmurs in healthy middle-aged individuals: innocent or clinically significant? A 35-year follow-up study of 2014 Norwegian men. J Intern Med (2011) 1.40
Trends in coronary heart disease mortality and morbidity and related factors in Finland. Cardiology (1985) 1.37
The validity of hospital discharge register data on coronary heart disease in Finland. Eur J Epidemiol (1997) 1.36
Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S). Am J Cardiol (1998) 1.32
Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke (1996) 1.29
Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. BMJ (1994) 1.29
Plasma insulin, serum lipids and lipoproteins in gall stone disease in non-insulin dependent diabetic subjects: a case control study. Gut (1990) 1.27
C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris. Ann Med (2001) 1.27
Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia (1993) 1.26
Decline of coronary heart disease mortality in Finland during 1983 to 1992: roles of incidence, recurrence, and case-fatality. The FINMONICA MI Register Study. Circulation (1996) 1.24
5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects. Circulation (1990) 1.22
Acute myocardial infarction (AMI) in Finland--baseline data from the FINMONICA AMI register in 1983-1985. Eur Heart J (1992) 1.20
Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels. Nat Med (1998) 1.20
Medial artery calcification predicts cardiovascular mortality in patients with NIDDM. Diabetes Care (1994) 1.20
Prolongation of the Q-T interval caused by sotalol--possible association with ventricular tachyarrhythmias. Eur Heart J (1981) 1.20
Lack of cellular and humoral immunological responses to oats in adults with coeliac disease. Gut (2000) 1.20
Factors related to long-term prognosis following acute myocardial infarction. Importance of left ventricular function. Scand J Rehabil Med (1975) 1.19
Subjective memory complaints and personality traits in normal elderly subjects. J Am Geriatr Soc (1994) 1.19
Atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and nondiabetic subjects in Finland. Diabetes Care (1988) 1.13
Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects. Diabetologia (1995) 1.13
APOE polymorphism and the hypertriglyceridemic effect of dietary sucrose. Am J Clin Nutr (2001) 1.13
Effects of 2 low-fat stanol ester-containing margarines on serum cholesterol concentrations as part of a low-fat diet in hypercholesterolemic subjects. Am J Clin Nutr (1999) 1.13
Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease. Arterioscler Thromb Vasc Biol (2000) 1.12
The significance of intensity of rehabilitation of stroke--a controlled trial. Stroke (1986) 1.11
Retinopathy predicts coronary heart disease events in NIDDM patients. Diabetes Care (1996) 1.10
Smoking is independently associated with high plasma insulin levels in nondiabetic men. Diabetes Care (1996) 1.10
GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis. Diabetes Care (1995) 1.09